Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications

Frontiers Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. - Abstract - Europe PMC

Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes

Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program - ScienceDirect

Non-small cell lung cancer molecular characterization of advanced disease with focus on sex differences: a narrative review - Bruno - Precision Cancer Medicine

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Genomic alterations of ERBB receptors in cancer: clinical implications

Biomarker Tests LUNGevity Foundation

Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer - European Medical Journal

Efficacy and immune modulation of KRAS G12C inhibitor sotorasib in mur by Teng Zhou, Minh Truong Do et al.

JCM, Free Full-Text

Cancers, Free Full-Text